Approval · Notice of Compliance 1004 · 2000
SENSORCAINE: Notice of Compliance 1004
Issued March 24, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1004
- Date
- March 24, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Local anesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SENSORCAINE | 01976141 | Marketed |
| SENSORCAINE | 01976168 | Marketed |
| SENSORCAINE | 02237777 | — |
Medicinal ingredients
- BUPIVACAINE HYDROCHLORIDE 2.5 MG per ML
- BUPIVACAINE HYDROCHLORIDE 5 MG per ML
- BUPIVACAINE HYDROCHLORIDE 7.5 MG per ML